Triton Distribution Systems, Inc. (OTCMKTS:TTDZ, TTDZ message board) is still able to keep the delicate balance at the peak of the rising trend, without major setbacks so far. The ticker had a rough patch at the end of the week, losing more than 17% to $0.0338, as it lined up among the most actively traded MMJ tickers on the OTC markets. TTDZ reached selling volumes of $1.3 million, as the general mood was subdued, with few stocks exceeding a dollar volume of $4 million.
TTDZ is doing its best to be kept on the radar, with constant updates on potential partnerships in the field of legalized cannabis. The latest PR describes a new deal, this time with Hemjoba, Inc. Thus, TTDZ potentially acquired yet another ready-made medical cannabis product, as companies prepare for a wider spread of the legislation to introduce cannabis sales to even more US states.
TTDZ manages to trade upward as the general Marijuana index is going through some transformations, seeking a new direction after a deep fallout in March. At this price, the ticker has a surprisingly stable outlook, compared to MMJ stocks in the same price range. Now, TTDZ still has the name change up its sleeve, and the event is expected to take place next week. The only thing to wait for is whether this will make the price move in response, or if the market has already discounted the news.
Investors’ forums still expect that TTDZ will make a faster run toward the five-cent price. Buyers also seem to trust the promises of TTDZ that it would deliver new products through its Green Cures, Inc. brand. For now, however, the sites of TTDZ are not selling any ready-made preparation, which means TTDZ lags behind other better-established MMJ companies.
For a more robust climb, we may look toward the stock of Creative Edge Nutrition, Inc. (OTCMKTS:FITX). This ticker managed to keep up the levels, and is again above $0.08, despite its link to Growlife, Inc. (OTCBB:PHOT), the suspended ticker that dragged down its partners a couple of weeks ago.
The promise of Green Cures focuses more on researching the various active ingredients of the cannabis plant, and delivering purified, targeted pharmaceutical doses. With this, TTDZ has moved away from the easier business model of producing cannabis edibles for medical or recreational use. This may mean that TTDZ will have to wait for more active revenues, which are almost immediate for companies offering more of the already established cannabis products.
Soon, TTDZ will match the price range of another in-demand cannabis company, CannaBusiness Group, Inc. (OTCMKTS:CANA).This Canadian firm is sinking for the past month toward $0.05, as the publicity slowed down. CANA is a part of the group of real estate companies that promise to serve the MMJ sector. Yet despite the $30 million in promised financing, and the changes in management, CANA did not inspire a lasting interest beyond the initial enthusiastic climb.
If you still like TTDZ for the potential to make a decent run, be aware that the whole sector remains shaky. While the company shows future potential, this won’t protect anyone from short-term fluctuations, which can lead to wide losses within days.
This entry passed through the Full-Text RSS service — if this is your content and you’re reading it on someone else’s site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers.